Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inflammatory Disease Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00063414
What this trial is testing

ISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Ionis Pharmaceuticals, Inc.
Large-scale testing (Phase 3)Study completedNCT01369355
What this trial is testing

Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)

Who this might be right for
Crohn's DiseaseColitisIBD+1 more
Janssen Research & Development, LLC 1,282
Testing effectiveness (Phase 2)Looking for participantsNCT07840326
What this trial is testing

A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)

Who this might be right for
Primary Progressive Multiple SclerosisPrimary Progressive MSPrimary Progressive Multiple Sclerosis (PPMS)+6 more
Sundance Biosciences, Inc. 20
Not applicableActive Not RecruitingNCT05496348
What this trial is testing

Study of Oral Upadacitinib to Assess Change in Disease Activity in Adult Participants With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 400
Not applicableLooking for participantsNCT07534852
What this trial is testing

NIMA-Colon Cancer Study

Who this might be right for
Colon Cancer
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 120
Post-approval studies (Phase 4)Ended earlyNCT00947674
What this trial is testing

Leukocytapheresis (LCAP) in Patients With Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Asahi Kasei Medical Co., Ltd. 52
Early research (Phase 1)UnknownNCT05743010
What this trial is testing

A Phase 1b Study to Evaluate APL-1401 in Patients With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Jiangsu Yahong Meditech Co., Ltd aka Asieris 36
Testing effectiveness (Phase 2)Ended earlyNCT04971005
What this trial is testing

Ocrelizumab or Alemtuzumab Compared With Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis - a Phase-2 Randomised Controlled Trial

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Universitätsklinikum Hamburg-Eppendorf 1
Large-scale testing (Phase 3)Study completedNCT03009396
What this trial is testing

Open Label Efficacy and Safety of Anti-MAP (Mycobacterium Avium Ssp. Paratuberculosis) Therapy in Adult Crohn's Disease

Who this might be right for
Crohn Disease
RedHill Biopharma Limited 54
Testing effectiveness (Phase 2)WithdrawnNCT04096573
What this trial is testing

Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
LG Chem
Testing effectiveness (Phase 2)Ended earlyNCT03977480
What this trial is testing

Phase II Study of Hemay007 in Patients With Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Tianjin Hemay Pharmaceutical Co., Ltd 70
Not applicableLooking for participantsNCT06669702
What this trial is testing

EXercise Therapy in Axial SpA, Inflammation and Biologic Therapy (ExTASI-B)

Who this might be right for
Axial SpondyloarthrithisInflammatory DiseasesArthritis
Loughborough University 60
Early research (Phase 1)Study completedNCT01290042
What this trial is testing

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.

Who this might be right for
Ulcerative ColitisCrohn's Disease
Amgen 43
Testing effectiveness (Phase 2)Looking for participantsNCT06226883
What this trial is testing

Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Who this might be right for
Inflammatory Bowel DiseasesCrohn's Disease
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) 385
Testing effectiveness (Phase 2)Study completedNCT00659802
What this trial is testing

Phase II Study of HMPL-004 in Patients With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Hutchison Medipharma Limited 224
Testing effectiveness (Phase 2)Looking for participantsNCT06764615
What this trial is testing

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

Who this might be right for
Crohn's DiseaseUlcerative Colitis
Takeda 192
Large-scale testing (Phase 3)WithdrawnNCT01593527
What this trial is testing

Canakinumab in the Treatment of Gouty Arthritis Flare(s) and Prevention of New Flares in Patients With Chronic Kidney Disease

Who this might be right for
Acute Gouty Arthritis
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Active Not RecruitingNCT06052059
What this trial is testing

Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)

Who this might be right for
Ulcerative Colitis
Merck Sharp & Dohme LLC 1,020
Large-scale testing (Phase 3)Ended earlyNCT01349673
What this trial is testing

The Safety and Tolerability of Budesonide Foam in Participants With Active Ulcerative Proctitis or Proctosigmoiditis

Who this might be right for
ProctitisProctosigmoiditis
Bausch Health Americas, Inc. 114
Testing effectiveness (Phase 2)Study completedNCT03648541
What this trial is testing

BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Boehringer Ingelheim 79
Next Page